ScrutarSign up free

Cigna Group (CI)

SEC filings, insider trading & institutional ownership from EDGAR.

NYSEFinancialsInsurance

The Cigna Group is a global health company, incorporated in Delaware in 1981 through its predecessor companies. It describes its mission as improving the health and vitality of those it serves by delivering a personalized, transparent and affordable health care experience. As of December 31, 2025, it had approximately 67,700 colleagues, more than 185 million customer relationships in more than 30 markets and jurisdictions, and about 1.7 million relationships with health care providers, clinics and facilities. It pairs pharmacy and medical capabilities to improve affordability, transparency and health outcomes, and has set five areas of focus under its Commitments to Better: easier access to care, better support, better value, accountability and transparency.

The company has two segments. Evernorth Health Services includes the Pharmacy Benefit Services and Specialty and Care Services operating segments. Pharmacy Benefit Services covers pharmacy benefits (retail network administration, benefit design consultation, drug utilization review, formulary and rebate management, medical drug management, group purchasing organization administration, value-based programs and the Evernorth Wholesale Marketplace) and home delivery pharmacy through Express Scripts Pharmacy and the EnGuide Pharmacy focused on GLP-1 customers. Specialty and Care Services includes Accredo specialty pharmacy, CuraScript SD health system services (specialty distribution to providers), and care services such as MD Live virtual care and EviCore benefits management. Cigna Healthcare includes U.S. Healthcare and International Health. U.S. Healthcare offers employer medical plans (Open Access Plus, LocalPlus, HMO and PPO options), consumer-driven products, and ACA-compliant individual and family plans in 11 states. It also offers behavioral health, consumer health engagement, cost containment, dental, pharmacy management and stop-loss solutions. International Health offers medical, dental, pharmacy, vision, life, accidental death and dismemberment, and disability coverage. Other Operations holds run-off and non-strategic businesses, and Corporate holds unallocated amounts. On March 19, 2025, the company sold its Medicare Advantage, Medicare stand-alone prescription drug plan, Medicare supplemental benefits and CareAllies businesses to Health Care Service Corporation.

Evernorth serves managed care organizations, health insurers, third-party administrators, employers, union-sponsored plans, workers' compensation plans, government health programs, providers, clinics and hospitals, including a majority of Cigna Healthcare's clients. Three clients drive significant segment revenue: Centene, Prime Therapeutics and the Department of War's TRICARE program. Cigna Healthcare offers administrative services only and insured funding options to employers, groups and individuals. International Health serves multinational employers, intergovernmental and nongovernmental organizations, and globally mobile individuals.

Operationally, Evernorth dispenses drugs through non-exclusive retail pharmacy networks, home delivery and specialty pharmacies. Express Scripts Pharmacy has 11 licensed pharmacies, including four fulfillment pharmacies in Arizona, Indiana, Missouri and New Jersey. EnGuide Pharmacy has two licensed pharmacies, including a fulfillment pharmacy in Ohio. The specialty pharmacy operation has 35 licensed pharmacies, and CuraScript runs four distribution centers. Pharmaceuticals are bought from manufacturers or authorized wholesalers, with one wholesaler supplying about half of purchases. Competitors include pharmacy benefit managers, retail, home delivery and specialty pharmacies, specialty drug distributors, health plans, third-party administrators, group purchasing organizations, clinical solutions and data analytics companies, and care services providers.

AI-summarized from Item 1 (Business) of the company’s most recent 10-K filing.

RevenueFY2025
$274.9B
▲ 11.2%YoY
Net incomeFY2025
$5.96B
▲ 73.5%YoY
Diluted EPSFY2025
$22.18
▲ 83.0%YoY
Insider net6 mo
+5.7K
shares5 sells0 buys
Institutions
62
$43.53B held

Financials

As reported to the SEC via XBRL, no adjustments

All financials →
Revenue & net income
$100B$200B$300B
FY2022FY2023FY2024FY2025
RevenueNet income
FY2025 highlightsfrom 10-K
Operating income$9.2B
Diluted EPS$22.18
Net margin2.2%

Latest filings

10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR

All filings →
FormFiledAccession
10-QNov 5, 2026EDGAR
8-KNov 5, 2026EDGAR
8-KOct 10, 2026EDGAR
8-KSep 30, 2026EDGAR
4Neville EverettSep 8, 2026EDGAR
4Evanko Brian CSep 3, 2026EDGAR
4Jones Nicole SAug 20, 2026EDGAR
4Jones Nicole SAug 6, 2026EDGAR

Insider trading

From Form 4 filings

All →
InsiderDateType
Neville EverettSep 3, 2026Sell
Evanko Brian CSep 1, 2026Grant / award
Jones Nicole SAug 18, 2026Sell
Jones Nicole SAug 5, 2026Option exercise
Jones Nicole SAug 4, 2026Sell

Top holders

13F & 13D/G • latest quarter

All →
HolderStakeFiledValue
BlackRock, Inc.8.9%Aug 7, 2026$6.46B
Vanguard Capital Management6.6%Aug 13, 2026$4.76B
STATE STREET CORPORATION4.8%Sep 22, 2026$3.5B
Dodge & Cox4.6%Aug 13, 2026$3.36B
Massachusetts Financial Services Company4.0%Aug 3, 2026$2.9B

CI's filings are public. The insight is one click away.

Scrutar's AI reads every CI filing and points out what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.

Analyze CI filingsNo credit cardAI reports included on the free plan

Never miss a CI filing.

Get an email when CI files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.

Free foreverNo account requiredOne-click unsubscribe

Protected by reCAPTCHA. Privacy & Terms

Companies related to CI

Peers identified from CI's own SEC filings.

Data as of Nov 8, 2026Source: SEC EDGAR.